This HTML5 document contains 195 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n13https://w3id.org/oc/corpus/br/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q28278620
rdf:type
wikibase:Item
schema:description
tudományos cikk 2012年の論文 научни чланак vitenskapelig artikkel مقالة علمية (نشرت في 24-11-2012) teaduslik artikkel mokslinis straipsnis мақолаи илмӣ 2012年論文 vitskapeleg artikkel научни чланак 2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած artigo científico (publicado na 2012) article scientific სამეცნიერო სტატია 2012年论文 bilimsel makale научна статия wetenschappelijk artikel (gepubliceerd op 2012/11/24) 2012年論文 articol științific artikull shkencor scientific article مقالهٔ علمی naučni članak article scientifique (publié 2012) 2012年论文 2012 nî lūn-bûn artículu científicu espublizáu en 2012 scienca artikolo article científic บทความทางวิทยาศาสตร์ bài báo khoa học 2012년 논문 2012年論文 articolo scientifico artigo científico мақолаи илмӣ 2012年论文 vedecký článok (publikovaný 2012/11/24) videnskabelig artikel (udgivet 2012) 2012年論文 tieteellinen artikkeli vetenskaplig artikel מאמר מדעי artigo científico (publicado na 2012) artículo científico publicado en 2012 επιστημονικό άρθρο наукова стаття, опублікована в листопаді 2012 2012年论文 wissenschaftlicher Artikel 2012 թվականի նոյեմբերին հրատարակված գիտական հոդված سائنسی مضمون научная статья 2012年論文 ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2012年论文 artikulong pang-agham ശാസ്ത്രപ്രബന്ധം​ artykuł naukowy vědecký článek publikovaný v roce 2012 2012年论文
p:P577
wds:Q28278620-45F9B1D5-30E6-481A-9361-B5073C3D351E
wdt:P577
2012-11-24T00:00:00Z
p:P407
wds:Q28278620-3546D1D4-1F00-4A2E-B2E4-E108324DD969
wdt:P407
wd:Q1860
p:P2860
wds:Q28278620-03282459-F242-4584-8428-3D7299DBBB89 wds:Q28278620-0D61915E-8734-4E83-9352-F40E8DE03BB6 wds:Q28278620-F2B7F21A-9BA0-451C-932B-EADB08CD8DD9 wds:Q28278620-FAD6EF2E-D280-4DDE-9174-937904350FE7 wds:Q28278620-FC940FF0-2B5D-42D4-A04C-C940B725EAD2 wds:Q28278620-81E97327-5FA9-45BF-B341-F9784C1DAD9D wds:Q28278620-83BD589B-DA6E-4052-93C3-2AF5C24D5113 wds:Q28278620-9484B5B3-B817-40BE-AA4F-62D4EA6BE80D wds:Q28278620-98FA5076-A708-4BFF-ACF3-1D457E03A215 wds:Q28278620-9C58880C-CFF9-4184-AC90-3BA6A0F98EAA wds:Q28278620-9DC693F7-EA54-41A0-9907-150E095DA10A wds:Q28278620-B66816A5-A1C5-4134-9C99-51054377565B wds:Q28278620-B69DFB2E-3D77-4B21-9923-37E34F817CD9 wds:Q28278620-C9177239-6E83-4B00-AED3-A86C7AEB7EDB wds:Q28278620-C932920B-CA07-4A11-80E9-DA90E995968E wds:Q28278620-DBB87DEA-216C-4385-BCE5-8585008E001C wds:Q28278620-480FEF14-0178-47AC-8211-738E53AFA370 wds:Q28278620-4F8128C0-9AEF-4000-ABD4-3FFCB181CB76 wds:Q28278620-533BBA0A-37D9-49C9-BCD1-12F090D95658 wds:Q28278620-5E75C92D-8588-4622-B641-4FB24928892E wds:Q28278620-623126F5-5D62-4C2B-95A3-5035E4AD4243 wds:Q28278620-627CF2E4-5C47-4B43-95DA-ECA6D92A4084 wds:Q28278620-7D2297D2-526E-417A-9670-1B002D4F6D01 wds:Q28278620-1CDE9728-A24C-4B75-9F7F-4025D459C300 wds:Q28278620-24EB6A9D-1B75-4C64-8BE5-8776BCCA032B wds:Q28278620-3959E6B3-214E-4CFA-924F-EA76A2ECD1D0 wds:Q28278620-3A84551B-3040-4DE2-BC5A-50C46803420E wds:Q28278620-3AEC7F3E-4E47-435B-B395-097AE8A89987
wdt:P2860
wd:Q28144207 wd:Q44825022 wd:Q50766232 wd:Q57492006 wd:Q51987968 wd:Q58642928 wd:Q53609763 wd:Q30922892 wd:Q36726382 wd:Q40810823 wd:Q57601974 wd:Q22241644 wd:Q78571161 wd:Q37484571 wd:Q84907800 wd:Q61651685 wd:Q22252938 wd:Q53482190 wd:Q28271008 wd:Q36026719 wd:Q45814039 wd:Q49151897 wd:Q51890331 wd:Q33400373 wd:Q48087197 wd:Q30053056 wd:Q37922644 wd:Q33381736
p:P2093
wds:Q28278620-081DAE9C-F6BF-476B-8BDE-DE6E40B052D0 wds:Q28278620-2F635EB2-96CE-4320-B257-997A3DF76C4E wds:Q28278620-33115FA8-ABEA-4358-8553-C570338772E6 wds:Q28278620-24685138-0B6D-467F-BE8D-71FA085B71BD wds:Q28278620-47F2FECD-7EB3-4D1F-A67F-B6EBD2FED8CF wds:Q28278620-4EDC47F3-1645-4DFC-A96A-A3FCAD678DD9 wds:Q28278620-4973DB8B-91A0-4FB7-8A5F-79E45278B6B6 wds:Q28278620-4D0D2621-37C5-40DD-803C-9C0795347B1C wds:Q28278620-48710C1E-0FC1-48C9-B5FE-B265EAE03FFB wds:Q28278620-68E403EA-A8C7-4110-8718-9DA34B727340 wds:Q28278620-55D48E01-F671-49D6-9AA3-32FF0B763601 wds:Q28278620-920F49EA-FD3E-475B-9532-1446747B27D9 wds:Q28278620-CE8206D9-F7AC-456F-AC8B-95313D22DF7A wds:Q28278620-A38EA6D4-C761-44EF-BB96-6C3A74363A40 wds:Q28278620-EFF2955B-6536-41E3-9F39-8B6EF992C68B wds:Q28278620-E760DED9-A165-4D8D-949A-0B6EB250B338
p:P3181
wds:Q28278620-4E12A930-8F23-43F7-8544-2F12615C37EC
wdtn:P3181
n13:52826
wdt:P2093
Tamara Miller Christian Confavreux Rupert Sandbrink Michael A Panzara Alasdair J Coles Douglas L Arnold Pedro Oyuela Elizabeth Fisher David H Margolin Cary L Twyman Jeffrey A Cohen D Alastair S Compston Krzysztof W Selmaj Edward J Fox Eva Havrdova Stephen L Lake
wdt:P3181
52826
rdfs:label
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
skos:prefLabel
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
schema:name
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
p:P50
wds:Q28278620-C37B9A44-C388-4CD4-AA36-C78D40C87891 wds:Q28278620-A20CBBDF-AC70-4343-9A86-FBE2D822D55D wds:Q28278620-59FFBE34-F270-4CAA-AD7F-C9AE7B23F306
wdt:P50
wd:Q83945935 wd:Q30001859 wd:Q20985921
p:P1476
wds:Q28278620-362A9D02-4388-4E42-9437-E5066AC5EBA1
wdt:P1476
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
p:P304
wds:Q28278620-192279FD-920D-4350-BA35-36FEC12DD057
wdt:P304
1829-39
p:P31
wds:Q28278620-E930F6A2-9552-456C-9C77-DFADAD1438EB
wdt:P31
wd:Q13442814
p:P921
wds:Q28278620-0E622866-7F2E-4DC5-9708-72083F632761 wds:Q28278620-24DC4C3C-CCFF-4C55-8E93-FAF93C3B7EE8
wdt:P921
wd:Q42824827 wd:Q8277
p:P698
wds:Q28278620-1C949FDB-8DFE-41DA-B965-60138A41D054
wdtn:P698
n10:23122650
wdt:P698
23122650
p:P1433
wds:Q28278620-410537EB-CE23-4FA7-BDBF-D32C146B7859
wdt:P1433
wd:Q939416
p:P433
wds:Q28278620-0E8338F4-8B94-4A17-992B-28240BD14DD8
p:P478
wds:Q28278620-2CD8527D-102F-4B28-B1BE-5DD0D322F02C
wdt:P433
9856
wdt:P478
380
p:P356
wds:Q28278620-707804D2-1CA0-475A-8638-3FE423C6C0B5
wdtn:P356
n11:S0140-6736(12)61768-1
wdt:P356
10.1016/S0140-6736(12)61768-1